cephalosporin c has been researched along with Healthcare-Associated Pneumonia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 10 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Echols, R; Matsunaga, Y; Menon, A; Portsmouth, S; Skaar, EP | 1 |
| Candel, FJ; González Del Castillo, J; Julián Jiménez, A; Matesanz, M | 1 |
| Abdelraouf, K; Nicolau, DP | 1 |
| Bassetti, M; Cattelan, A; Giacobbe, DR; Mussini, C; Vena, A | 1 |
| Bisanti, A; Diaz, E; Martin-Loeches, I; Rodriguez, A | 1 |
| Ariyasu, M; Clevenbergh, P; Echols, R; Kaye, KS; Kollef, M; Matsunaga, Y; Menon, A; Nagata, TD; Pogue, JM; Shorr, AF; Timsit, JF; Wunderink, RG; Zeitlinger, M | 1 |
| Bruno, C; Carmelitano, P; Castanheira, M; De Anda, C; Huntington, JA; Johnson, MG; Motyl, M; Rhee, EG; Yu, B | 1 |
| Aronica, R; Cancelli, F; Mastroianni, CM; Mauro, V; Oliva, A; Romani, F; Savellon, G; Valeri, S | 1 |
| Bruno, CJ; Butterton, JR; Huntington, JA; Jensen, EH; Kivistik, Ü; Kollef, MH; Martin-Loeches, I; Nováček, M; Réa-Neto, Á; Rhee, EG; Shime, N; Timsit, JF; Wolf, DJ; Wunderink, RG; Yu, B | 1 |
| Syed, YY | 1 |
| Deng, J; Li, SL; Li, YT; Lin, HL; Niu, JJ; Shen, X; Yang, TC; Yu, YW; Zhao, QF | 1 |
| Agnelli, F; Baratta, F; Colombo, F; Frantellizzi, V; Pani, A; Pastori, D; Scaglione, F | 1 |
3 review(s) available for cephalosporin c and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Ceftolozane-tazobactam in nosocomial pneumonia.
Topics: Adult; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pseudomonas Infections; Tazobactam | 2022 |
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Double-Blind Method; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Randomized Controlled Trials as Topic; Urinary Tract Infections | 2021 |
Off-label use of ceftaroline fosamil: A systematic review.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Endocarditis, Bacterial; Healthcare-Associated Pneumonia; Humans; Meningitis; Off-Label Use | 2019 |
4 trial(s) available for cephalosporin c and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study.
Topics: Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Cross Infection; Double-Blind Method; Healthcare-Associated Pneumonia; Homeostasis; Humans; Iron | 2022 |
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Male; Meropenem; Pneumonia, Bacterial | 2021 |
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Healthcare-Associated Pneumonia; Humans; Meropenem; Multicenter Studies as Topic; Multilocus Sequence Typing; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Tazobactam; Treatment Outcome | 2021 |
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Equivalence Trials as Topic; Female; Healthcare-Associated Pneumonia; Humans; Logistic Models; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Tazobactam | 2021 |
5 other study(ies) available for cephalosporin c and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Healthcare-Associated Pneumonia; Humans; Mice; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa | 2023 |
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pharmaceutical Preparations; Polymyxins; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome | 2020 |
Ceftolozane and tazobactam for the treatment of hospital acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series.
Topics: Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans | 2021 |
Risk factors and molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Xiamen, China.
Topics: Aged; beta-Lactamases; Case-Control Studies; Cephalosporins; China; Female; Genotyping Techniques; Healthcare-Associated Pneumonia; Hospitals; Humans; Intubation, Gastrointestinal; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Multilocus Sequence Typing; Multivariate Analysis; Odds Ratio; Risk Factors | 2017 |